Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

GLP-1 medications have been going viral for their transformative effects, but now people are raising concerns about a ...

AROUND half a million Brits use weight loss drugs. And that number is expected to double in the next year with the rise in ...

Weight loss jabs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro) have surged in popularity, becoming one ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

The South Korean office of the Danish pharmaceutical company Novo Nordisk recently requested the local authorities to permit ...

Some people using Ozempic in clinical studies reported weight loss. Ozempic ... Association includes Wegovy in its treatment recommendations for obesity. A large review of studies compared GLP ...

Clinical trials have shown that Wegovy can lead to an average weight loss of 15-18% over 68 weeks. It is approved for use in individuals with a BMI of 30 or greater or those with a BMI of 27 or ...

A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...